S Koni Reddy's Insider Trades & SAST Disclosures
S Koni Reddy's most recent trade in Concord Drugs Ltd. was a Acquisition of 25,000 Equity Shares done at an average price of Rs. 27.2 . Disclosure was reported to the exchange on Sept. 30, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
S Koni Reddy's has made SAST transactions in Concord Drugs Ltd. recently where a Acquisition of 25,000 shares done . Disclosure was reported to the exchange on Sept. 30, 2021.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concord Drugs | S. Koni Reddy | Promoter & Director | Acquisition | 30 Sep 2021 | 25,000 | 1,000,000 (11.44%) | 0.29% | 27.2 | 679,447 | 02 Sep 2021 28 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
| Concord Drugs | S Koni Reddy | Promoter | Acquisition | 01 Oct 2021 | 25,000 | 1,000,000 (11.44%) | 0.29% | - | 02 Sep 2021 28 Sep 2021 |
SAST (29(2)) | - | Market |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.